JUN and cancer: The notion that YAP/TAZ and AP1 converge at regulating a core, cancer-specific gene expression program is particularly appealing in light of in vitro and in vivo results validating this model, and of the many ways by which YAP/TAZ activation feedbacks on expression and regulation of AP1 family members.